Go to Page # Page of 20

Bronchopulmonary Dysplasia: Chronic Lung Disease of Infancy and Long-Term Pulmonary Outcomes

 Lauren M. Davidson, Sara K. Berkelhamer
Description: Bronchopulmonary dysplasia (BPD) is a chronic lung disease most commonly seen in premature infants who required mechanical ventilation and oxygen therapy for acute respiratory distress. While advances in neonatal care have resulted in improved survival rates of premature infants, limited progress has been made in reducing rates of BPD. Lack of progress may in part be attributed to the limited therapeutic options available for prevention and treatment of BPD. Several lung-protective strategies have been shown to reduce risks, including use of non-invasive support, as well as early extubation and volume ventilation when intubation is required.
Views: 1060
Domain: Medical
Category: Therapy
Contributing Organization: Semantic Scholar
 ‐ More of their Presentations
Maxims of Tech: Rules of Engagement for a Fast Changing Environment
Journal of

Clinical Medicine

Bronchopulmonary Dysplasia: Chronic Lung Disease
of Infancy and Long-Term Pulmonary Outcomes
Lauren M. Davidson and Sara K. Berkelhamer *
Department of Pediatrics, University at Buffalo SUNY, Buffalo, NY 14228, USA; lmdavids@buffalo.edu
* Correspondence: saraberk@buffalo.edu; Tel.: +1-716-878-7945
Academic Editor: David Barnes
Received: 1 November 2016; Accept ... See more

Recent Presentations

Oncolytic Immunotherapeutics Leadership

The presentation and the accompanying oral commentary contain forward-looking statements within the meaning of the relevant securities laws of the Republic of Korea and the United

SillaJen Inc
18 March, 2018

Basket and Umbrella Trial Designs in Oncology

Historically, phase I conducted with mixture of solid tumors, then phase II and III oncology trials were histopathologic focused (e.g. lung cancer study, breast cancer study, etc.)

Eric Polley
17 March, 2018

Multidisciplinary Approachs in Cancer

The oncology framework is increasingly complex, entailing multiple interactions of all stakeholders involved: patients, European and national policy makers, European and internatio

16 March, 2018